NYSE · Healthcare · Drug Manufacturers - General
Johnson & Johnson
JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. CEO Joaquin Duato · Market cap $651.3B.
$270.24
+2.87 · +1.07%
52w hi $276.4752w lo $173.33
Off 52w high 5.3%
49
ROUTINE
Current InsiderScore
Corp · 90d
9
0 buys · 9 sales
Cong · 90d
4
1 buys · 3 sales
Signals ≥ 60 · 12mo
5
0 strong · 5 notable
Analyst consensus
Strong Buy
Avg PT $282.08
Section 01
Recent Form 4 filings
30 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Aug 17 | Jennifer L Taubert | EVP, WWC. Innovative Medicine | Sell | 15,000 | $263.36 | −$3.95M | 27 |
| Aug 13 | Joaquin Duato | CEO and Chairman of the Board | Sell | 102,315 | $261.00 | −$26.70M | 44 |
| Aug 13 | Joaquin Duato | CEO and Chairman of the Board | Sell | 20,976 | $262.00 | −$5.50M | 37 |
| Aug 06 | Elizabeth Forminard | EVP, Chief Legal Officer | Sell | 9,344 | $257.75 | −$2.41M | 34 |
| Aug 06 | Elizabeth Forminard | EVP, Chief Legal Officer | Sell | 6,574 | $255.93 | −$1.68M | 34 |
| Aug 05 | Joaquin Duato | CEO and Chairman of the Board | Sell | 6,523 | $258.74 | −$1.69M | 31 |
| Aug 05 | Joaquin Duato | CEO and Chairman of the Board | Sell | 41,957 | $258.06 | −$10.83M | 40 |
| Jul 20 | Vanessa Broadhurst | EVP, Global Corp Affairs | Sell | 23,054 | $251.27 | −$5.79M | 48 |
| Jun 11 | Kathryn E Wengel | EVP, Chief TO and Risk Officer | Sell | 10,000 | $241.15 | −$2.41M | 27 |
| Feb 27 | Robert J Decker | VP Corporate Controller | Sell | 4,075 | $247.87 | −$1.01M | 30 |
| Feb 18 | Timothy Schmid | EVP, WW Chair, MedTech | Sell | 13,625 | $244.20 | −$3.33M | 34 |
| Feb 18 | Timothy Schmid | EVP, WW Chair, MedTech | Sell | 8,998 | $244.53 | −$2.20M | 34 |
| Feb 17 | Joseph J Wolk | Exec VP, CFO | Sell | 12,066 | $242.87 | −$2.93M | 34 |
| Feb 17 | Joseph J Wolk | Exec VP, CFO | Sell | 19,241 | $242.99 | −$4.68M | 38 |
| Feb 17 | James D. Swanson | EVP, CIO | Sell | 20,521 | $242.70 | −$4.98M | 34 |
| Feb 17 | Joseph J Wolk | Exec VP, CFO | Sell | 33,386 | $242.75 | −$8.10M | 49 |
| Feb 17 | Vanessa Broadhurst | EVP, Global Corp Affairs | Sell | 6,197 | $243.39 | −$1.51M | 30 |
| Feb 17 | REED JOHN C | EVP, Innovative Medicine, R&D | Sell | 21,721 | $243.00 | −$5.28M | 48 |
| Feb 17 | REED JOHN C | EVP, Innovative Medicine, R&D | Sell | 29,927 | $243.00 | −$7.27M | 48 |
| Feb 17 | Joseph J Wolk | Exec VP, CFO | Sell | 24,961 | $242.68 | −$6.06M | 52 |
| Feb 13 | James D. Swanson | EVP, CIO | Sell | 22,191 | $243.71 | −$5.41M | 37 |
| Feb 13 | James D. Swanson | EVP, CIO | Sell | 19,368 | $243.76 | −$4.72M | 34 |
| Jan 26 | Joaquin Duato | CEO and Chairman of the Board | Sell | 48,782 | $221.48 | −$10.80M | 55 |
| Jan 26 | Joaquin Duato | CEO and Chairman of the Board | Sell | 51,218 | $220.99 | −$11.32M | 52 |
| Nov 26 | John G Morikis | Buy | 1,250 | $206.15 | +$258K | 57 | |
| Oct 17 | REED JOHN C | EVP, Innovative Medicine, R&D | Sell | 21,721 | $192.71 | −$4.19M | 37 |
| Sep 04 | Jennifer L Taubert | EVP, WWC. Innovative Medicine | Sell | 56,471 | $177.81 | −$10.04M | 33 |
| Aug 22 | Joaquin Duato | CEO and Chairman of the Board | Sell | 125,824 | $179.21 | −$22.55M | 52 |
| Aug 15 | Joseph J Wolk | Exec VP, CFO | Sell | 16,820 | $176.91 | −$2.98M | 49 |
| Jul 17 | REED JOHN C | EVP, Innovative Medicine, R&D | Sell | 19,137 | $163.55 | −$3.13M | 37 |
Section 02
Recent STOCK Act disclosures
13 disclosures on file
| Disclosed | Legislator | Chamber · State | Action | Range | Midpoint | Delay | Score |
|---|---|---|---|---|---|---|---|
| Aug 17 | Rich McCormick | House | Sell | $1,001 - $15,000 | $8K | 18 d | 39 |
| Jul 16 | Thomas H. Kean | House · NJ | Sell | $1,001 - $15,000 | $8K | 17 d | 39 |
| Jul 07 | Lloyd Doggett | House · TX | Buy | $1,001 - $15,000 | $8K | 28 d | 49 |
| Jul 16 | Thomas H. Kean | House · NJ | Sell | $1,001 - $15,000 | $8K | 44 d | 35 |
| Jun 11 | Ro Khanna | House · CA | Sell | $1,001 - $15,000 | $8K | 41 d | 35 |
| May 13 | Ro Khanna | House · CA | Buy | $15,001 - $50,000 | $33K | 30 d | 35 |
| Apr 14 | Thomas H. Kean | House · NJ | Sell | $1,001 - $15,000 | $8K | 19 d | 64 |
| Apr 07 | Richard Dean Dr McCormick | House · GA | Sell | $1,001 - $15,000 | $8K | 19 d | 69 |
| Apr 14 | John Boozman | Senate · AR | Sell | $1,001 - $15,000 | $8K | 26 d | 61 |
| Apr 08 | Lloyd Doggett | House · TX | Buy | $1,001 - $15,000 | $8K | 29 d | 69 |
| Apr 09 | Ro Khanna | House · CA | Sell | $1,001 - $15,000 | $8K | 34 d | 60 |
| Feb 20 | Thomas H. Kean | House · NJ | Sell | $15,001 - $50,000 | $33K | 28 d | 39 |
| Aug 05 | Tommy Tuberville | Senate · AL | Sell | $15,001 - $50,000 | $33K | 645 d | 28 |
Section 03
InsiderScore history
Rolling 12 months · peak score per month
SepOctNovDecJanFebMarAprMayJunJulAug